A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Clinical trial NCT06018129 · TERMINATED

Trial details

NCT number: NCT06018129
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Classical Hodgkin Lymphoma Non-Hodgkin Lymphoma

Start date: 2023-09-21
Primary completion: 2025-02-05
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.